Stephen Hoge, President at Moderna, Inc. (MRNA), sold 314 shares at $43.30 ($14K) on 2024-12-03, disclosed to the SEC on 2024-12-04.
Open-market sale of $14k MRNA by President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| MRNA | SELL | 2026-07-16 | $3.6M | — | Filing → |
| MRNA | SELL | 2026-06-17 | $2.7M | — | Filing → |
| MRNA | SELL | 2026-05-18 | $2.6M | — | Filing → |